Windtree Therapeutics Inc.
13F holders, Q3 2024 (September 30)8holders +3
3new positions
0sold out
$2.39avg. 13F price*
At the end of Q3 2024, 8 institutions reported holding Windtree Therapeutics Inc. in their 13F filings, up 3 from Q2 2024. 3 opened new positions and 0 sold out. The largest holders were Armistice Capital, LLC ($375K), Morgan Stanley ($9K) and Tower Research Capital LLC (TRC) ($5K).
- Company
- Windtree Therapeutics Inc.
- CUSIP
- 97382D501
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $384K |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 161,532 shares bought, net +161,532 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Armistice Capital, LLC | 0.01% | New | 157,000 | $375K |
| Morgan Stanley | 0.00% | New | 3,712 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +28.8% | 1,940 | $5K |
| UBS Group AG | 0.00% | Add +12800.0% | 387 | $925 |
| Bank of America Corp. | 0.00% | No change | 4 | $10 |
| Activest Wealth Management | 0.00% | No change | 2 | $5 |
| IFP Advisors, Inc | 0.00% | No change | 1 | $2 |
| Royal Bank of Canada | 0.00% | New | 2 | $0 |
"% of holder's portfolio" is WINDTREE THERAPEUTICS INC's weight in each manager's 13F, not the share of Windtree Therapeutics Inc. the manager owns.